Medicus Pharma to present at Bio International Conference, outlining SkinJect registrational plan

Medicus Pharma Ltd

Medicus Pharma Ltd

MDCX

0.00
  • Medicus will attend the Bio International Conference in San Diego on June 22-25, 2026.
  • A company presentation is scheduled for June 24, 2026 at 3:00 p.m. Pacific time at the San Diego Convention Center.
  • Update expected on SkinJect registrational plans following Phase 2 results showing 55% histological clearance, 64% clinical clearance in the 200 ug cohort.
  • Teverelix precision-medicine endometriosis study update expected, alongside broader development plans in prostate cancer and urology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220730PRIMZONEFULLFEED9750183) on June 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.